(+)-Norfenfluramine is the major hepatic metabolite of (+)-fenfluramine and is primarily responsible for the anorexic effect, as well as side effects; (+)-norfenfluramine causes vasoconstriction and a blood pressure increase in rats with normal blood; more potent than fenfluramine at inducing dopamine release; acts primarily on the cytoplasmic pool of serotonin.
